UDG Healthcare (LON:UDG) had its target price boosted by stock analysts at Peel Hunt from GBX 860 ($11.57) to GBX 880 ($11.84) in a research note issued on Thursday. The brokerage presently has an “add” rating on the stock. Peel Hunt’s price objective would suggest a potential upside of 4.34% from the company’s current price.
A number of other equities analysts also recently weighed in on UDG. Numis Securities downgraded shares of UDG Healthcare to a “reduce” rating and set a GBX 765 ($10.30) target price for the company. in a research note on Thursday, November 9th. Liberum Capital reaffirmed a “hold” rating and issued a GBX 884 ($11.90) target price on shares of UDG Healthcare in a research note on Wednesday, November 15th. N+1 Singer boosted their target price on shares of UDG Healthcare from GBX 770 ($10.36) to GBX 841 ($11.32) and gave the stock a “hold” rating in a research note on Wednesday, November 1st. Jefferies Group boosted their target price on shares of UDG Healthcare from GBX 830 ($11.17) to GBX 855 ($11.51) and gave the stock a “hold” rating in a research note on Wednesday, October 4th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a GBX 815 ($10.97) target price on shares of UDG Healthcare in a research note on Thursday, November 30th. One investment analyst has rated the stock with a sell rating and six have given a hold rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of GBX 826.43 ($11.12).
UDG Healthcare (LON UDG) opened at GBX 843.37 ($11.35) on Thursday. UDG Healthcare has a 12-month low of GBX 632.50 ($8.51) and a 12-month high of GBX 963 ($12.96).
COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3078627/udg-healthcare-udg-pt-raised-to-gbx-880-at-peel-hunt.html.
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.